Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway
about
Anaplastic lymphoma kinase: signalling in development and diseasep130Cas mediates the transforming properties of the anaplastic lymphoma kinaseEmerging importance of ALK in neuroblastomaTargeting EML4-ALK driven non-small cell lung cancer (NSCLC)Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell linesALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiationAnaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cellsAn evolutionary conserved role for anaplastic lymphoma kinase in behavioral responses to ethanol.The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Alk is a transcriptional target of LMO4 and ERα that promotes cocaine sensitization and reward.Pathobiology of ALK+ anaplastic large-cell lymphoma.Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways.What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain.Mass spectrometry-based proteomic studies of human anaplastic large cell lymphoma.Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system.Clinical Challenges to Current Molecularly Targeted Therapies in Lung CancerEnhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entityThe connections between neural crest development and neuroblastoma.Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.Treating ALK-positive lung cancer--early successes and future challenges.Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma.ALK alterations and inhibition in lung cancer.Pleiotrophin, the angiogenic and mitogenic growth factor: levels in serum and synovial fluid in rheumatoid arthritis and osteoarthritis : And correlation with clinical, laboratory and radiological indices.Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacophore model derived from known ligands crystallized with ALK.Neurite Outgrowth in PC12 Cells Stimulated by Components from Dendranthema × grandiflorum cv. "Mottenohoka" Is Enhanced by Suppressing Phosphorylation of p38MAPK.Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.Identification of NPM-ALK interacting proteins by tandem mass spectrometry.HB-GAM/Pleiotrophin and Midkine are differently expressed and distributed during retinoic acid-induced neural differentiation of P19 cells.Anaplastic Lymphoma Kinase in Cutaneous MalignanciesActivating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684.Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.Dominant negative effectors of heparin affin regulatory peptide (HARP) angiogenic and transforming activities.A ligand-inducible epidermal growth factor receptor/anaplastic lymphoma kinase chimera promotes mitogenesis and transforming properties in 3T3 cells.A ligand-inducible anaplastic lymphoma kinase chimera is endocytosis impaired.ALK in Neuroblastoma: Biological and Therapeutic Implications.
P2860
Q24312329-88735A26-4417-4BEF-82D2-70B40C5668A0Q24315788-54BB18E9-5AFC-4777-BA5F-1A3759FC6163Q26858819-65BA6175-2EDF-4EE4-9BCC-EB93F3E8E4B5Q27002155-89743666-EC52-4234-B719-6954D2570962Q28214508-5B400708-9804-4853-BFB5-606092E1BDF8Q28564190-171BF9BE-3E47-4109-A21B-3C302DE055EFQ28571575-E4F89AFC-F8D8-4BAC-8BDF-DEB6B88C69D7Q33974947-62880017-5CE7-4125-95B0-0C06538378BBQ34221605-5B74130D-113F-452A-82CC-A17003603349Q35283020-96CC291E-F87C-4D7B-BAEA-E67889D5BAC8Q35393768-694DECC4-C604-47BD-B6E0-51226C25BAEBQ36007756-1CA744BF-564B-4D8F-8430-08ECA564E92BQ36110572-3733D0BA-4065-49BD-A1B4-ADD9462CE63DQ36132014-E3D460AE-210D-49E3-B9E8-6453E9668434Q36199954-EF816D20-1245-452D-B45B-B55B70318E3BQ36511656-328C032E-F507-4204-BDFD-5275186B6483Q36935686-4148C7A0-AA09-4665-A11C-ECD7D06B0205Q36972377-89C37E4B-3F37-4F7C-B05E-7071B58DF671Q37073265-2CA3607A-3DF3-4EDB-B317-7B3F2C1D5145Q37268913-095D4B4E-24E8-4327-977D-30EE61A6E849Q37836006-6059584A-7380-4F44-A1A9-771E8A6E408DQ37848818-D9CAA1C5-0D6A-4942-A2B3-C562AC969178Q37999657-86E40A58-8B25-4DD6-BD72-4721CA7B8E1FQ38096472-780088CE-F03D-4D81-B74E-746E1EB7D5F6Q38106810-B2A49940-2C4A-4F00-AA59-FA0E3FF45800Q38756797-2AB9ADB2-DE8C-42B2-A4C6-B00DBA6012AFQ38820412-ED5409EC-C5AB-4B55-97F6-8ADB325FDBDBQ39140572-D35C7D9A-4F66-4FA8-8BC8-AD75CE2105DEQ39252246-10CDBC55-0939-47F3-BBD4-92722F8B82CEQ39300506-04AAB2A0-53D1-4800-AEE9-FF5B52ADB822Q40424263-1158007B-E6E2-455E-9E60-551F2ADEAD27Q40589160-C2259D70-2EA3-4BA5-9535-FC9454DF0BF9Q40601782-13C4515D-E2EA-4E36-9CCB-A76DB45E3B99Q41670874-30ED7F61-7495-4B4E-B473-3B931D09F0F7Q42727617-B9B268EB-56D7-4BB1-BA87-AF96A804E19CQ42812907-A2F70ADE-F776-499C-AD0F-C94727CB4019Q42813705-2F8D6DF5-BD30-49C7-87A0-9FA5F308955AQ42817137-5D1AAAA0-AE73-4D47-818E-CA05C54457B1Q42832954-A883A685-8CFC-42FF-8B29-70DFF7E9384BQ52324760-783F8C10-0097-498F-AEBF-11BEE27A2A75
P2860
Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activation of anaplastic lymph ...... tivated protein kinase pathway
@ast
Activation of anaplastic lymph ...... tivated protein kinase pathway
@en
Activation of anaplastic lymph ...... tivated protein kinase pathway
@nl
type
label
Activation of anaplastic lymph ...... tivated protein kinase pathway
@ast
Activation of anaplastic lymph ...... tivated protein kinase pathway
@en
Activation of anaplastic lymph ...... tivated protein kinase pathway
@nl
prefLabel
Activation of anaplastic lymph ...... tivated protein kinase pathway
@ast
Activation of anaplastic lymph ...... tivated protein kinase pathway
@en
Activation of anaplastic lymph ...... tivated protein kinase pathway
@nl
P2093
P2860
P356
P1476
Activation of anaplastic lymph ...... tivated protein kinase pathway
@en
P2093
P2860
P304
P356
10.1074/JBC.M007333200
P407
P577
2001-03-23T00:00:00Z